Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06890962 · ClinicalTrials.gov registry record · NA
Citicoline Dose on Energy Drink Efficacy
A NA study, sponsored by Nathaniel Jenkins.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT06890962 is a NA study that has completed, run by Nathaniel Jenkins. The registered enrollment target is 34 participants.
The verdict
NCT06890962, a NA study, has completed, sponsored by Nathaniel Jenkins.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how the doses of cognitive-enhancing ingredients such as citicoline and caffeine effect the efficacy of acute energy drink consumption for improving cognitive performance (primary outcome), gaming performance, mood, energy expenditure, and fat oxidation. This study will utilize an In vivo acute response, randomized, double-blind, placebo controlled, cross-over trial study design. Participants will complete consent, complete screening, and then undergo familiarization and complete four experimental study visits. In brief, participants will consume a commercially available energy drink specifically formulated to improve cognitive performance with the standard dose of Cognizin, a reduced dose of Cognizin, a reduced dose of caffeine and Cognizin, or a placebo (water, which will be carbonated, matched for flavor, mouthfeel, etc.), then complete a battery of computer-based cognitive performance test, tasks in a video game (Tetris) to assess video game performance, have their resting metabolism analyzed, and then assessments of mood. Following a 1-week washout period, participants will return and consume one of the four remaining beverages and complete the same tasks. They will participate in four experimental visits, each time consuming a different beverage until they have consumed all beverages and completed all necessary tasks. Question(s) and Hypotheses (stated in null) Q: Does acute consumption of a new formulations (reduced active ingredients \[citicoline and caffeine\]) of a commercially available energy drink elicit similar improvements in cognitive performance, mood, energy expenditure and fat oxidation in young adults than the standard, currently marketed dose to formulation? H1: Acute consumption of the commercially available energy drink with standard dosing will improve cognitive performance compared to the reduced dose beverages and the placebo. H2: Acute consumption of the commercially available energy drink with
Interventions
- DIETARY_SUPPLEMENT Energy drink consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2023-06-09 |
| Est. Completion | 2023-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06890962
The ClinicalTrials.gov registry entry for NCT06890962 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nathaniel Jenkins, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Energy drink consumption is the first listed.
NCT06890962 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06890962 about?
NCT06890962 is a clinical study titled "Citicoline Dose on Energy Drink Efficacy". The purpose of this study is to determine how the doses of cognitive-enhancing ingredients such as citicoline and caffeine effect the efficacy of acute energy drink consumption for improving cognitive performance (primary outcome), gaming performance, mood, energy expenditure, and fat oxidation. Thi...
What is the current status of trial NCT06890962?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2023-06-09. Estimated completion is 2023-12-01.
What interventions are being tested in trial NCT06890962?
The interventions under investigation include: Energy drink consumption (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06890962?
This trial is sponsored by Nathaniel Jenkins, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.